Prescription drug · ANDA
Md Gastroview NDC 0019-4816
diatrizoate meglumine and diatrizoate sodium · Diatrizoate meglumine 600 mg/mL; Diatrizoate sodium 100 mg/mL · Solution · Oral, Rectal · Liebel-Flarsheim Company LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0019-4816-04 | 00019481604 | 25 BOTTLE, GLASS in 1 BOX (0019-4816-04) / 30 mL in 1 BOTTLE, GLASSMarketed from Aug 31, 2009 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Md Gastroview
- Generic name (nonproprietary)
- diatrizoate meglumine and diatrizoate sodium
- Active ingredients
- Diatrizoate meglumine — 600 mg/mLDiatrizoate sodium — 100 mg/mL
- Dosage form
- Solution
- Route
- Oral, Rectal
- Labeler
- Liebel-Flarsheim Company LLCNDC labeler code 0019
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 087388
- Marketing start
- Listing expires
- Other FDA classes
- X-Ray Contrast Activity (Mechanism)X-Ray Contrast Activity (Mechanism)
- Identifiers
- Product ID 0019-4816_79425e73-456a-458a-986d-baf4291584a2SPL ID 79425e73-456a-458a-986d-baf4291584a2SPL set ID b348b1cf-6250-4ab6-b2bf-3bff86628c53UNII 3X9MR4N98U, V5403H8VG7UPC 0300194816044
- Pharmacologic class
- Radiographic Contrast Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400019481604followed by a unit qualifier and the quantityPackage 00019-4816-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE MD-Gastroview (Diatrizoate Meglumine and Diatrizoate Sodium Solution) is indicated for radiographic examination of segments of the gastrointestinal tract (esophagus, stomach, proximal small intestine, and colon). The preparation is particularly indicated when a more viscous agent such as barium sulfate, which is not water-soluble, is not feasible or is potentially dangerous. MD-Gastroview may also be used as an adjunct to contrast enhancement in computed tomography of the torso (body imaging); the preparation is indicated, in conjunction with intravenous administration of a radiopaque contrast agent, when unenhanced imaging may not provide sufficient definition in dist…
Excerpt only. Read the full label for complete information.
About NDC 0019-4816
- What is NDC 0019-4816?
- 0019-4816 is the product NDC for Md Gastroview, Diatrizoate meglumine 600 mg/mL; Diatrizoate sodium 100 mg/mL solution, listed with the FDA by Liebel-Flarsheim Company LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Md Gastroview (Diatrizoate meglumine and diatrizoate sodium).
- What is the active ingredient?
- Diatrizoate meglumine, Diatrizoate sodium.
- Who is the labeler?
- Liebel-Flarsheim Company LLC, NDC labeler code 0019. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Md Gastroview?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.